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Abstract
Background: Osteoarthritis of the hip is successfully treated by total hip arthroplasty with metal-on-
polyethylene articulation. Polyethylene wear debris can however lead to osteolysis, aseptic loosening and
failure of the implant. Large head metal-on-metal total hip arthroplasty may overcome polyethylene wear
induced prosthetic failure, but can increase systemic cobalt and chromium ion concentrations. The
objective of this study is to compare two cementless total hip arthroplasties: a conventional 28 mm metal-
on-polyethylene articulation and a large head metal-on-metal articulation. We hypothesize that the latter
arthroplasties show less bone density loss and higher serum metal ion concentrations. We expect equal
functional scores, greater range of motion, fewer dislocations, fewer periprosthetic radiolucencies and
increased prosthetic survival with the metal-on-metal articulation.
Methods: A randomized controlled trial will be conducted. Patients to be included suffer from non-
inflammatory degenerative joint disease of the hip, are aged between 18 and 80 and are admitted for
primary cementless unilateral total hip arthroplasty. Patients in the metal-on-metal group will receive a
cementless titanium alloy acetabular component with a cobalt-chromium liner and a cobalt-chromium
femoral head varying from 38 to 60 mm. Patients in the metal-on-polyethylene group will receive a
cementless titanium alloy acetabular component with a polyethylene liner and a 28 mm cobalt-chromium
femoral head. We will assess acetabular bone mineral density by dual energy x-ray absorptiometry
(DEXA), serum ion concentrations of cobalt, chromium and titanium, self reported functional status
(Oxford hip score), physician reported functional status and range of motion (Harris hip score), number
of dislocations and prosthetic survival. Measurements will take place preoperatively, perioperatively, and
postoperatively (6 weeks, 1 year, 5 years and 10 years).
Discussion: Superior results of large head metal-on-metal total hip arthroplasty over conventional hip
arthroplasty have been put forward by experts, case series and the industry, but to our knowledge there
is no randomized controlled evidence.
Conclusion: This randomized controlled study has been designed to test whether large head metal-on-
metal cementless total hip arthroplasty leads to less periprosthetic bone density loss and higher serum
metal ion concentrations compared to 28 mm metal-on-polyethylene cementless total hip arthroplasty.
Trial registration: Netherlands Trial Registry NTR1399
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Background
Painful osteoarthritis of the hip can be successfully treated
by total hip arthroplasty (THA). Conventional total hip
prostheses consist of a 28 mm metal head and a polyeth-
ylene cup. Polyethylene wear debris can however lead to
osteolysis, bone loss, aseptic loosening and eventually
failure of the implant, especially in high demand young
patients [1]. Metal-on-metal (MM) total hip arthroplasty
is an alternative to overcome polyethylene wear induced
prosthetic failure. The MM wear rate is reported to be 20
to 100 times lower than conventional polyethylene wear
rates, roughly 6 μm per year [2]. MM wear rate is also
influenced by the size of the articulation and its clearance
(i.e. the difference between the radius of the head and the
shell): larger heads show lower wear rates provided they
have a low clearance [3]. Another advantage of larger head
sizes seems to be an increased range of motion and a
reduced number of dislocations [4]. The main claim of
metal-on-metal articulations is a reduction of wear and a
subsequent lower incidence of periprosthetic osteolysis.
Since osteolysis is implicated in the early phases of pros-
thetic loosening and failure, it is essential to accurately
quantify periprosthetic osteolysis. Conventional radiol-
ogy is not sensitive and accurate enough to detect small
amounts of osteolysis, but dual energy x-ray absorptiom-
etry (DEXA) is able to detect even small defects in the
periprosthetic bone in the acetabulum [5]. In spite of the
advantages of low wear and fewer dislocations, metal-on-
metal hip prostheses increase systemic cobalt and chro-
mium ion concentrations [6]. The long term effects of
these ions are unknown, but concerns are hypersensitiv-
ity, mutagenicity and carcinogenicity [7].
The objective of this study is to conduct a randomized
controlled trial to compare two cementless total hip
arthroplasties: a conventional 28 mm metal-on-polyeth-
ylene articulation and a metal-on-metal large head articu-
lation. We hypothesize that the large head metal-on-metal
arthroplasties show less bone mineral density loss and
higher serum metal ion concentrations (primary outcome
parameters). We expect equal functional scores, greater
range of motion, less dislocations, fewer periprosthetic
radiolucencies and increased prosthetic survival with the
MM articulation (secondary outcome parameters). The
present paper reports on the design of the study.
Methods
Study design
A randomized controlled trial will be conducted and con-
cealed allocation will be used to allocate patients to either
metal-on-polyethylene or metal-on-metal cementless
total hip arthroplasty. The randomization procedure is
based on sequentially numbered opaque sealed enve-
lopes, produced by an external institution not involved in
the selection, clinical care and evaluation of the patients.
The study design, procedures and informed consent are
approved by the local Medical Ethical Committee (regis-
tration number 2005–42). The trial is registered in the
Netherlands Trial Registry (NTR1399). Guidelines of the
Consort Statement are followed [8].
Study population
The study will be conducted at the Department of Ortho-
paedic Surgery of the Martini Hospital, which is a large
teaching hospital in the city of Groningen, the Nether-
lands. Patients to be included suffer from non-inflamma-
tory degenerative joint disease of the hip including
osteoarthritis, avascular necrosis and traumatic arthritis,
are aged between 18 and 80 and are admitted for primary
cementless unilateral THA. Patients with active infection,
revision arthroplasty, marked bone loss, and unwilling-
ness or inability to follow instruction are excluded. Partic-
ipation in the study is voluntary and informed consent is
required. The inclusion period is planned from September
2006 to September 2009.
Intervention
Metal-on-metal (MM)
Patients in the metal-on-metal group will receive a metal-
on-metal articulation total hip arthroplasty, a cementless
plasma sprayed porous coated titanium alloy acetabular
component with a cobalt-chromium liner (M2a-Mag-
num™, Biomet) and a cobalt-chromium femoral head
with a carbon concentration between 0.20% and 0.30%.
The radial clearances of the articulations vary between
17.5 and 150 micrometers. The head sizes vary from 38 to
60 mm, depending on the shell sizes which range from 44
to 66 mm. The geometry of the patient determines the
largest possible shell size and head size to be implanted.
Metal-on-polyethylene (MP)
Patients in the metal-on-polyethylene group will receive a
metal-on-polyethylene total hip arthroplasty, a cement-
less plasma sprayed porous coated titanium alloy acetab-
ular component (Mallory-Head®, Biomet) with a
polyethylene liner (ArCom™, Biomet) and a 28 mm
cobalt-chromium femoral head with a carbon concentra-
tion between 0.20% and 0.30%. In both the MM and MP
groups the same cementless femoral component is used: a
proximally plasma sprayed porous coated titanium alloy
(Ti6Al4V) stem (Mallory-Head®, Biomet).
According to the surgeon's preference, a posterolateral or
anterolateral surgical approach in lateral decubitus posi-
tion is used. Antibiotic prophylaxis with a first-generation
cephalosporin will be given preoperatively and during the
first twenty-four hours intravenously. All patients will be
treated postoperatively following a standardized protocol,
in terms of analgesia and mobilization. As prophylaxisBMC Musculoskeletal Disorders 2008, 9:136 http://www.biomedcentral.com/1471-2474/9/136
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against thrombosis, oral anticoagulation by coumarin-
derivate is given 6 weeks postoperatively.
Measurements
In this study the following outcome parameters will be
assessed: bone densitometry and serum metal ion concen-
tration (primary outcome parameters), self reported func-
tional status, physician reported functional status, range
of motion, number of dislocations, radiographic evalua-
tion and prosthetic survival (secondary outcome parame-
ters). Measurements will take place preoperatively,
perioperatively, and postoperatively (6 weeks, 1 year, 5
years and 10 years).
Bone densitometry
Bone mineral density (BMD) measurements will be per-
formed using a dual energy x-ray absorptiometry (DEXA)
scanner (Hologic Inc., Bedford, Mass., United States) in
order to calculate bone density changes around the
acetabular component. Four horizontal regions of interest
(ROI) are defined, as suggested by Wilkinson [9]. In addi-
tion, an extra ROI is defined in the os ilium to serve as
control. The manufacturer's metal removal software will
be used. The contralateral normal hip will be scanned fol-
lowing a standard manufacturer's protocol to establish
BMD in the femoral neck, trochanter, intertrochanteric,
total hip and Ward's triangle sites.
Serum metal ion concentration
Serum ion concentrations for cobalt, chromium and tita-
nium will be determined by venous blood sampling.
Cobalt and titanium concentrations are analyzed by
inductively coupled plasma mass spectrometry (ICP-MS;
Agilent 7500 series, Agilent Technologies) and chromium
is measured by grafite furnace atomic absorption spec-
trometry with Zeeman correction (GFAAS; Varian 220Z,
Varian Inc.). The patients' sera may also be used to assess
cytokine levels and effects of these ions on osteoblast
cells.
Perioperative measurements
Surgical approach, surgical time and intra-operative blood
loss are recorded. Perioperative complications will be reg-
istered, including hip dislocations.
Self-reported and physician reported functional status and range of 
motion
The validated Oxford self-rating questionnaire will be
used to assess self reported functional status [10]. The val-
idated Harris Hip Score is used to assess patient and phy-
sician reported functional status, as well as range of
motion [11,12].
Radiographic evaluation
During every follow-up visit standard supine anteroposte-
rior (AP) pelvic hip radiographs (with 115% magnifica-
tion) will be taken. The AP radiographs at 6 weeks will
serve as baseline, and will be compared to the X-rays 5
years and 10 years postoperatively. Radiographs are
reviewed for presence of femoral radiolucent lines and
scored according to the 7 zones described by Gruen et al.
[13]. Peri-acetabular radiolucencies are assessed according
to the three zones of De Lee and Charnley [14]. The scor-
ing will be undertaken by an independent reviewer.
Sample size
It is our hypothesis that large head metal-on-metal arthro-
plasties will show less bone mineral density loss and
higher serum metal ion concentrations compared to the
conventional 28 mm metal-on-polyethylene articula-
tions. In order to detect a least clinical relevant difference
in bone mineral density (BMD) of 0.25 g/cm2 with a
standard deviation of 0.4, 41 patients are needed in each
group (alpha 0.05, power 0.80). Based on previous work
with cemented THA we expect a drop-out rate of 10%, but
we also expect conversion to cemented cups if adequate
cementless fixation fails. We therefore aim to include 50
patients in each group. Comparable studies also used 50
patients in each group [15,16]. In order to detect a clinical
difference of 2.5 μg/liter in serum metal ion concentration
with a standard deviation of 1.8, 8 patients per group are
needed (alpha 0.05, power 0.80). To compensate for
patients withdrawn from the study, (the first) 15 patients
will be included in each group. A comparable study used
10 patients in each group [17].
Statistical analysis
The Statistical Package for the Social Sciences version 14.0
for Windows (SPSS Inc.) will be used. Group comparisons
are based on intention-to-treat analysis. Non-parametric
tests are used for comparisons of means within groups
(Wilcoxon's Signed Ranks Test) and between groups
(Mann-Whitney Test) if our expectation of a skewed dis-
tribution of Oxford and Harris Hip scores postoperatively
is confirmed. Chi-square (Fisher's Exact) tests are
employed for analyses of categorical variables. Cumula-
tive implant survival is calculated by Kaplan-Meier time
series (Mantel-Cox log rank test). A two-sided p-value of <
0.05 is assumed to be significant.
Discussion
Superior results of large head metal-on-metal total hip
arthroplasty over conventional hip arthroplasty have been
put forward by experts, case series and the industry, but to
our knowledge there is no randomized controlled evi-
dence. This study will compare both arthroplasties.
Periprosthetic bone density loss will be the main focus. In
the short term we will be able to determine whether largePublish with BioMed Central    and   every 
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head articulations increase clinical range of motion and
reduce the number of dislocations. Furthermore, the trial
will provide insight in short-term and long-term serum
metal ion levels. A related research project will focus on
the effects of metal ions on human osteoblast cells in
vitro. This is important since the long-term risks of sys-
temic metal ion exposure are unknown. Major pitfalls in
orthopaedic surgery research have been the absence of a
control group and the lack of randomization. This study
overcomes both these drawbacks.
Conclusion
This randomized controlled study has been designed to
test whether large head metal-on-metal cementless total
hip arthroplasty leads to less periprosthetic bone density
loss and higher serum metal ion concentrations compared
to 28 mm metal-on-polyethylene cementless total hip
arthroplasty.
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